Abstract P1-10-19: Skin, and nail, infections associated with the addition of pertuzumab to trastuzumab-based chemotherapy
Conclusions: We believe these infections are a result of combining pertuzumab with trastuzumab as 2 pts received no concurrent chemotherapy. An awareness of this complication is critical as some infections may be life-threatening. We have initiated patient education to ensure awareness of this potential complication.Citation Format: Mortimer JE, Yuan Y, Jung J, Kruper L, Stewart D, Chung S, Yu WK, Mendelsohn M, D'Apuzzo M, Tegtmeier B, Dadwal S. Skin, and nail, infections associated with the addition of pertuzumab to trastuzumab-based chemotherapy. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P1-10-19.
Source: Cancer Research - Category: Cancer & Oncology Authors: Mortimer, J., Yuan, Y., Jung, J., Kruper, L., Stewart, D., Chung, S., Yu, W., Mendelsohn, M., D'Apuzzo, M., Tegtmeier, B., Dadwal, S. Tags: Poster Session Abstracts Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Cellulitis | Chemotherapy | Coccidioidomycosis (Valley Fever) | Docetaxel | Education | Enterococcus | HER2 | Herceptin | Infectious Diseases | Men | MRSA | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Oral Cancer | Renal Failure | Skin | Skin Biopsy | Staphylococcus Aureus | Superbugs | Taxotere | Universities & Medical Training | Women